NASDAQ:DBVT

Dbv Technologies S.a Stock News

etoro logo Buy DBVT
*Your capital is at risk
$17.70
-0.530 (-2.91%)
At Close: Jun 03, 2026
Châtillon, France, June 3, 2026 DBV Technologies Announces the Results of its 2026 Combined General Meeting Shareholders approved all proposed resolutions DBV Technologies (Euronext: DBV – ISIN: FR
Châtillon, France, June 2, 2026 DBV Technologies Announces First Participant Screened in THRIVE Phase 2 Study of the VIASKIN ® Peanut Patch in Infants ages 6 through 12 Months with Peanut Allergy Th

Combined General Meeting of June 3, 2026

04:30pm, Wednesday, 13'th May 2026
Châtillon, France, May 13, 2026 Combined General Meeting of June 3, 2026 Procedures for Obtaining Information and Preparatory Documents for the Combined General Meeting DBV Technologies (Euronext: DB
Châtillon, France, May 12, 2026 DBV Technologies to Participate in the H.C. Wainwright 4th Annual BioConnect Investor Conference at Nasdaq DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – N
Châtillon, France, April 30, 2026 DBV Technologies Reports First Quarter 2026 Financial Results Reported cash and cash equivalents of $229 million as of March 31, 2026 —providing funding into the s
Here is how COMPASS Pathways PLC Sponsored ADR (CMPS) and DBV Technologies S.A. (DBVT) have performed compared to their sector so far this year.
DBV Technologies S.A. (DBVT) reported positive Phase 3 VITESSE results for Viaskin Peanut, advancing toward blockbuster sales projections exceeding $2 billion. My model estimates Viaskin Peanut's U.S.
DBV Technologies (DBVT) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
The mean of analysts' price targets for DBV Technologies (DBVT) points to a 79% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among a
Information Regarding the Total Number of Voting Rights and  Total Number of Shares of the Company as of March 31, 2026
Shares of DBV Technologies S.A. (NASDAQ: DBVT - Get Free Report) have been assigned an average recommendation of "Moderate Buy" from the nine ratings firms that are covering the firm, Marketbeat Ratin
Châtillon, France, March 26, 2026 DBV Technologies Announces Filing of 2025 Annual Report on Form 10-K and Universal Registration Document DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – N
Châtillon, France, March 26, 2026 DBV Technologies Reports Full Year 2025 Financial Results and Business Update Continued advancing the VIASKIN® Peanut Patch clinical development programs in peanut-
Châtillon, France, March 24, 2026 DBV Technologies to Join CAC Mid 60 and SBF 120 Indices Following Euronext Paris Annual Review Changes went into effect on Monday, March 23, 2026 DBV Technologies (E
DBV Technologies S.A. (NASDAQ: DBVT - Get Free Report)'s share price gapped up before the market opened on Friday. The stock had previously closed at $20.06, but opened at $21.49. DBV Technologies sha
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE